R
Richard E. Champlin
Researcher at University of Texas MD Anderson Cancer Center
Publications - 1500
Citations - 73470
Richard E. Champlin is an academic researcher from University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Transplantation & Hematopoietic stem cell transplantation. The author has an hindex of 138, co-authored 1402 publications receiving 66917 citations.
Papers
More filters
Journal ArticleDOI
Once Daily i.v. Busulfan and Fludarabine (i.v. Bu-Flu) Compares Favorably with i.v. Busulfan and Cyclophosphamide (i.v. BuCy2) as Pretransplant Conditioning Therapy in AML/MDS
Borje S. Andersson,Marcos de Lima,Peter F. Thall,Xuemei Wang,Daniel R. Couriel,Martin Korbling,Soonja Roberson,Sergio Giralt,Betty Pierre,James A. Russell,Elizabeth J. Shpall,Roy B. Jones,Richard E. Champlin +12 more
TL;DR: Results support replacing BuCy +/- ATG with Bu-Flu +/- rabbit-antithymocyte globulin (ATG), and warrant a prospective comparison between allogeneic HSCT and conventional induction/consolidation chemotherapy for AML in CR1.
Journal ArticleDOI
Treatment of Acute Myelogenous Leukemia: A Prospective Controlled Trial of Bone Marrow Transplantation Versus Consolidation Chemotherapy
Richard E. Champlin,Winston G. Ho,Robert Peter Gale,Drew J. Winston,Michael T. Selch,Ronald T. Mitsuyasu,Carl Lenarsky,Robert Elashoff,Jacob Zighelboim,Stephen A. Feig +9 more
TL;DR: Data show that bone marrow transplantation is more effective than consolidation chemotherapy in preventing leukemia relapse, but overall survival was not improved in this study.
Journal ArticleDOI
Common Emergence of Amantadine- and Rimantadine-Resistant Influenza A Viruses in Symptomatic Immunocompromised Adults
Janet A. Englund,Richard E. Champlin,Philip R. Wyde,Hagop M. Kantarjian,Robert L. Atmar,Jeffrey J. Tarrand,Hassan Yousuf,Helen L. Regnery,Alexander Klimov,Nancy J. Cox,Estella Whimbey +10 more
TL;DR: It is concluded that development of antiviral resistance in immunocompromised individuals should be considered when they have been treated with antivirals and have shed influenza virus for a prolonged period and isolates from five of six patients were resistant.
Journal ArticleDOI
Long-term outcome of patients given transplants of mobilized blood or bone marrow: A report from the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation.
Norbert Schmitz,Mary Eapen,Mary M. Horowitz,Mei-Jie Zhang,John P. Klein,J. Douglas Rizzo,Fausto R. Loberiza,Alois Gratwohl,Richard E. Champlin +8 more
TL;DR: Outcomes after allogeneic peripheral-blood stem cell (PBSC) and bone marrow (BM) transplantation in 706 patients with leukemia obtained long-term follow up on 141 PBSC and 272 BM recipients to represent the early experience with PBSC grafts.
Journal ArticleDOI
Outcome of bone marrow transplantation patients requiring mechanical ventilation.
Armando J. Huaringa,Francisco Leyva,Sergio Giralt,Jose J. Blanco,Jaime Signes-Costa,Hector Velarde,Richard E. Champlin +6 more
TL;DR: The ICU survival rate of BMT patients who developed pulmonary complications and required mechanical ventilation was 18%.